KIR3DL1 and COVID-19: In these individuals, we also observed significant activation of KIR+RA+ T cells during the early phase of COVID‐19 compared to the follow‐up at 2 and 4 weeks and compared to SARS‐CoV‐2 negative controls (Figure 6j).